Andrew Guggenhime, President and CFO at Vaxcyte, Inc. (PCVX), sold 14,000 shares at $60.22 ($843K) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Scheduled sale ($843k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |